Catherine Brisson

Dr. Brisson joined Neurana Pharmaceuticals in 2018 and is currently Vice President of Regulatory Affairs and Quality. Dr. Brisson has more than 20 years of experience in the biotechnology, pharmaceutical, and medical device industries with strong expertise and broad scientific and operational understanding in regulatory strategy, quality, manufacturing operations, and product/process development areas. Prior to Neurana, Dr. Brisson held positions in both startups and established companies, most recently as Chief Operating Officer at Stellar Biotechnologies. Earlier roles were focused on quality and regulatory operations at MacuSight and Teva Parenteral Products.

Dr. Brisson holds a Ph.D. in Chemistry from the University of North Carolina.